AZ Sint-Lucas & Volkskliniek
- Address
- lock Available on a paid plan
Digestive and Immune-Mediated Diseases
At AZ Sint-Lucas & Volkskliniek, clinical research in gastro-enterology focuses strongly on digestive system diseases and immune system diseases, especially Crohn's disease, ulcerative colitis, and other forms of inflammatory bowel disease. These studies are mainly designed to improve disease control, reduce relapse, and find better long-term treatment strategies for patients with chronic intestinal inflammation.
- Therapeutic focus on Digestive System Diseases and Immune System Diseases
- Main conditions include Crohn's disease, ulcerative colitis, and inflammatory bowel disease type unclassified
- Trials aim to improve symptom control, maintain remission, and prevent postoperative recurrence
The site is also involved in studies evaluating new biologic and immune-targeted approaches for patients who have not responded well to standard care.
Cardiovascular and Metabolic Research
Another major area of research at the site covers cardiovascular diseases and nutritional and metabolic diseases. The trials include people with heart failure, atherosclerotic cardiovascular disease, hypertension, and chronic kidney disease in type 2 diabetes mellitus. The overall goal is to test new ways to lower cardiovascular risk, improve heart function, and slow disease progression in patients with complex cardiometabolic conditions.
- Key fields: Cardiovascular Diseases and Nutritional and Metabolic Diseases
- Conditions studied include heart failure, hypertension, and atherosclerotic cardiovascular disease
- Research aims to reduce major cardiovascular events and improve long-term outcomes
These studies reflect a broad effort to address both prevention and treatment in patients at elevated cardiovascular risk.
Oncology and Advanced Cancer Care
The site also supports a wide range of cancer studies across neoplasms, with a particular emphasis on breast cancer, ovarian cancer, prostate cancer, lung cancer, colorectal cancer, and urothelial carcinoma. These trials are generally focused on testing new treatment combinations, extending disease control, and improving outcomes for patients with advanced or recurrent cancers.
- Therapeutic area: Neoplasms
- Main cancers include breast cancer, ovarian cancer, prostate cancer, lung cancer, and colorectal cancer
- Research aims to improve survival, delay progression, and refine treatment options for advanced disease
At AZ Sint-Lucas & Volkskliniek, oncology research spans both common and difficult-to-treat tumors, with studies often centered on better disease control after standard therapy.
Autoimmune, Skin, and Neuromuscular Disorders
Clinical trials at this hospital also explore immune system diseases, skin and connective tissue diseases, and nervous system diseases. The research includes atopic dermatitis, hidradenitis suppurativa, myasthenia gravis, amyotrophic lateral sclerosis, and multifocal motor neuropathy. These studies are intended to evaluate new therapies that may relieve symptoms, improve function, and support longer-term disease management.
- Focus areas include Immune System Diseases, Skin and Connective Tissue Diseases, and Nervous System Diseases
- Conditions studied include atopic dermatitis, hidradenitis suppurativa, myasthenia gravis, and amyotrophic lateral sclerosis
- Trials aim to improve symptom relief, disease stability, and patient quality of life
These investigations show a strong interest in both chronic inflammatory skin disease and rare neurological conditions.
Respiratory, Infectious, and Other Specialized Studies
Beyond its main specialty areas, the site participates in studies on bacterial infections and mycoses, environment and public health, and several other complex conditions. Examples include critically ill patients with infection, eosinophilic esophagitis, infertility, and transthyretin amyloidosis with cardiomyopathy. These trials are aimed at improving treatment effectiveness, refining care pathways, and addressing unmet needs across a diverse patient population.
- Broader research spans Bacterial Infections and Mycoses and Environment and Public Health
- Includes studies in eosinophilic esophagitis, infectious disease, infertility, and amyloidosis
- Purpose is to improve care quality, treatment effectiveness, and clinical outcomes in specialized settings
The diversity of topics highlights the site’s role in both routine and highly specialized clinical research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 12 therapeutic areas and 15 of 126 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 121 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 20 by active trials.
- 1Janssen Cilag International3active
lock +19 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB6trials
lock +16 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AZ Sint-Lucas & Volkskliniek
lock Showing 1 of 68 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| 2022-501606-35-00 – Randomized, multicenter, open-label, Phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRα-high recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers who have not progressed after second-line platinum-based chemotherapy plus bevacizumab (GLORIOSA). | AbbVie Deutschland GmbH & Co. KG | Phase I | Not Yet Recruiting | Feb 2024 | — |
IMP list
lock Showing 1 of 126 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Infliximab | 6 | Unknown | 2021-12-21 | 2024-06-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
